MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mca.0000000000001648

Медицинская библиотека · Coronary artery disease · 2026

Duration of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for bifurcation lesions: a systematic review and meta-analysis.

Suruagy-Motta Ricardo F O, Tirelli-Rocha Julia, Almeida Luiz Guilherme Silva, Aguiar-Barros Ana Beatriz P, Mendes Lucas Lima, Dexheimer da Silva Leonardo, Modi Kalgi, Cox-Alomar Pedro, de Melo Pedro Henrique Magalhães Craveiro, Filho Evandro Martins, Abizaid Alexandre, Pileggi Brunna

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The optimal duration of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention for coronary bifurcation lesions remains uncertain. This meta-analysis focused on comparing ischemic and bleeding outcomes between short-term (≤6 months) and long-term (>6 months) DAPT in this high-risk subgroup.

METHODS

We included six studies comprising 12 066 patients with bifurcation lesions treated with drug-eluting stents and either short- or long-term DAPT. Pooled relative risk (RR) and 95% confidence intervals (CI) were calculated for major adverse cardiovascular events (MACE), all-cause and cardiac mortality, myocardial infarction, stent thrombosis, stroke, bleeding, and target lesion revascularization.

RESULTS

Short-term DAPT was associated with significantly higher risks of MACE (RR 1.79; 95% CI 1.05-3.07), all-cause mortality (RR: 2.78; 95% CI: 1.49-5.19), cardiac death (RR 2.29; 95% CI 1.34-3.91), and stent thrombosis (RR: 4.90; 95% CI: 2.78-8.66). Although the risks of myocardial infarction (RR: 1.75; 95% CI: 0.69-4.47), stroke (RR: 1.07; 95% CI: 0.61-1.67), bleeding (RR: 1.49; 95% CI: 0.24-9.48), and target lesion revascularization (RR: 1.35; 95% CI: 0.85-2.12) did not reach statistical significance, the effect estimates consistently favored long-term DAPT.

CONCLUSION

In patients undergoing percutaneous coronary intervention for bifurcation lesions, short-term DAPT was associated with significantly worse ischemic outcomes, including increased rates of MACE, death, and stent thrombosis. These findings support the use of extended DAPT duration as the preferred strategy in this anatomical subgroup, with treatment tailored according to individual bleeding risk.

Для цитирования: Suruagy-Motta Ricardo F O, Tirelli-Rocha Julia, Almeida Luiz Guilherme Silva, Aguiar-Barros Ana Beatriz P, Mendes Lucas Lima, Dexheimer da Silva Leonardo, Modi Kalgi, Cox-Alomar Pedro, de Melo Pedro Henrique Magalhães Craveiro, Filho Evandro Martins, Abizaid Alexandre, Pileggi Brunna. Duration of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for bifurcation lesions: a systematic review and meta-analysis.. Coronary artery disease. 2026. DOI: 10.1097/mca.0000000000001648.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.